We use cookies for a better user experience. Read our Privacy Policy

I Agree

Joint Pain Injections Market

Joint Pain Injections Market (Joint Type: Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of Spine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031

Joint Pain Injections Market Outlook 2031

  • The global joint pain injections market was valued at US$ 4.7 Bn in 2021
  • The global market is projected to grow at a CAGR of 7.8% from 2022 to 2031
  • The global joint pain injections market is anticipated to reach more than US$ 9.8 Bn by the end of 2031

Analysts’ Viewpoint on Joint Pain Injections Market Scenario

The global joint pain injections market is expected to be driven by the rise in awareness about joint problems, significant unmet medical needs, and increase in geriatric population. New product development is, therefore, a major trend gaining traction in the global market. Key players in the joint pain injections market are focusing on developing innovative products to meet customer demand and increase their market share. For instance, injections of platelet-rich plasma and placental tissue matrix have proven to be effective in reducing the rate of infection, pain, and inflammation at the joint site. Rise in government expenditure on research & development for the production of affordable medications is creating value-grab opportunities for market players.

Joint Pain Injections Market

Joint Pain Injections Market Introduction

Injections for joint pain are usually administered directly into the joint to relieve pain and minimize swelling and discomfort. Joint discomfort is particularly common in the elderly population as a result of pre-existing illnesses or diseases. Musculoskeletal conditions such as arthritis and sacroiliac joint pain that cause pain and inflammation could contribute to joint discomfort. Rise in prevalence of osteoarthritis and rheumatoid arthritis; and increase in need for affordable treatments for such conditions are expected to increase the scope for joint pain injections market during the forecast period.

Request a sample to get extensive insights into the Joint Pain Injections Market

High Unmet Needs of Patients with Joint Pain to Drive Global Joint Pain Injections Market

Joint pain due to arthritis is a prevalent complaint among people. It is also a significant contributor to reduced mobility and impairment. Currently, the available therapy options are insufficient, as they primarily concentrate on symptom alleviation and pain management. There are no medicines that can reverse or stop the progression of arthritis. Demand for new treatment options for joint pain is high, as people do not get relief from the already available medications. This is expected to drive the global joint pain injections market.

Rise in Prevalence of Arthritis and Other Bone-related Disorders to Propel Global Joint Pain Injections Market

Arthritis is the most common cause of adult impairment globally. According to the Arthritis Foundation, osteoarthritis is the biggest cause of chronic impairment among the world's population. It ranks sixth among all forms of disability globally. Moreover, it is one of the most widespread musculoskeletal disorders, affecting 10% of the world's population aged over 60. In high-income countries, osteoarthritis affects up to 80% of those over 65, as it becomes more common with age. As the world's population ages, degenerative joint disease illnesses such as osteoarthritis are likely to affect at least 130 million people by 2031, according to projections by the Arthritis Foundation. This is likely to augment the global joint pain injections market in the next few years.

Request a custom report on Joint Pain Injections Market

Growth in Sale of Hyaluronic Acid Injections to Create Lucrative Opportunities for Manufacturers

In terms of injection type, the global joint pain injections market has been divided into corticosteroid injections, hyaluronic acid injections, and others. The hyaluronic acid injections segment is projected to account for significant share of the global market during the forecast period. Large patient pool, preference for injections over surgeries, and approval of knee injections for the treatment of knee osteoarthritis are some of the factors that contribute to the increase in sale of hyaluronic acid injections. Furthermore, hyaluronic acid injections are quite effective in the treatment of knee osteoarthritis, while other treatments are contraindicated. This is likely to create lucrative opportunities for manufacturers to gain revenue benefits.

Increase in Prevalence of Knee & Ankle Injuries and Knee-related Disorders Bolstering Demand for Joint Pain Injections

Based on joint type, the knee & ankle segment accounted for major share of the global market in 2021. The segment is expected to grow at a high CAGR during the forecast period. Rise in prevalence of knee & ankle injuries and increase in incidence of knee-related disorders such as osteoarthritis and rheumatoid arthritis across the globe are contributing to the segment's large market share. The prevalence of knee osteoarthritis has doubled in the U.S. since the mid-20th century, largely due to the increase in life expectancy.

Rise in Preference for Viscosupplementation Augmenting Hospital Pharmacies Segment

In terms of distribution channel, the global joint pain injections market has been divided into hospital pharmacies, retail pharmacies, and online pharmacies. The hospitals pharmacies segment is projected to account for major share of the global market in 2021. This can be ascribed to the rise in number of hospital admissions due to the increase in preference for new treatment options such as viscosupplementation.

Regional Outlook of Global Joint Pain Injections Market

North America is projected to account for major share of the global joint pain injections market during the forecast period. This can be ascribed to the high acceptance of viscosupplementation with hyaluronic acid products along with significant number of people in the region being covered by medical insurance. Furthermore, viscosupplementation has been approved by the U.S. FDA for the treatment of knee osteoarthritis. The U.S. dominated the joint pain injections market in North America in 2021 due to the presence of a large patient pool, high acceptance of newer orthobiologic injections such as platelet-rich plasma, and increase in geriatric population in the country.

Europe was the second largest region of the global joint pain injections market in terms of share in 2021. This can be ascribed to the rise in prevalence of joint pain among the population, increase in incidence of osteoarthritis, high acceptance of new treatments, surge in geriatric population, and approval of innovative products by the European Union. Germany led the joint pain market in the region in 2021 owing to its large patient population. The usage of hyaluronic acid is expected to rise significantly in Germany due to the increase in demand for effective treatments for osteoarthritis.

The market in Asia Pacific is anticipated to grow at a high CAGR during the forecast period due to the presence of a large patient pool, increase in treatment penetration, surge in geriatric population, and rise in awareness about joint-related disorders in India and China.

Analysis of Key Players in Global Joint Pain Injections Market

The global joint pain injections market is highly fragmented, with a small number of large-scale vendors controlling majority of the share. Most companies are investing significantly in comprehensive research and development activities, primarily to create innovative products. Expansion of product portfolios and mergers & acquisitions are the prominent strategies adopted by key players. The global joint pain injections market report includes various sections such as joint pain injections market drivers, joint pain injections market analysis, and challenges and opportunities in the joint pain injections market. Allergan plc, Pfizer, Inc., Sanofi, Anika Therapeutics, Inc., Ferring B.V., Bioventus, Flexion Therapeutics, Inc., Zimmer Biomet Holdings, Inc., Seikagaku Corporation, and Chugai Pharmaceutical Co., Ltd. are the key players operating in the global join pain injections market.

Key Developments in Global Joint Pain Injections Market

  • In September 2021, Novartis announced that the U.S. Food and Drug Administration (FDA) had granted LNA043 Fast Track Designation for the treatment of osteoarthritis of the knee
  • In July 2017, South Korea’s Ministry of Food and Drug Safety approved the first gene therapy for OA developed by TissueGene, a Maryland-based company
  • In March 2017, Bristol-Myers Squibb entered into a collaboration with CytomX Therapeutics, Inc., a leading biopharmaceutical company. This collaboration was aimed toward the development of novel therapies with eight additional targets for probody therapeutics.

Each of these players has been profiled in global joint pain injections market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Global Joint Pain Injections Market Snapshot

Attribute

Detail

Market Size Value in 2021

US$ 4.7 Bn

Market Forecast Value in 2031

More than US$ 9.8 Bn

Growth Rate

(CAGR) for 2022-2031

7.8%

Forecast Period

2022–2031

Historical Data Available for

2017–2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2021)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • Joint Type
    • Knee & Ankle
    • Hip Joint
    • Shoulder & Elbow
    • Facet Joints of Spine
    • Others
  • Injection Type
    • Corticosteroid Injections
    • Hyaluronic Acid Injections
    • Others
  • Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies

Regions Covered

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Spain
  • Italy
  • Japan
  • China
  • India
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa

Companies Profiled

  • Allergan plc
  • Pfizer, Inc.
  • Sanofi
  • Anika Therapeutics, Inc.
  • Ferring B.V.
  • Bioventus
  • Flexion Therapeutics, Inc.
  • Zimmer Biomet Holdings, Inc.
  • Seikagaku Corporation
  • Chugai Pharmaceutical Co., Ltd.

Customization Scope

Available upon request

Pricing

Available upon request

Joint Pain Injections Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

How big was the global joint pain injections market in 2021?

The global joint pain injections market was valued at US$ 4.7 Bn in 2021.

How big will be the global joint pain injections market in 2031?

The global joint pain injections market is projected to reach more than US$ 9.8 Bn by 2031.

What was the CAGR of the global joint pain injections market from 2017 to 2021?

The global joint pain injections market grew at a CAGR of 7.2% from 2017 to 2021.

What will be the CAGR of the global joint pain injections market during the forecast period (2022–2031)?

The global joint pain injections market is anticipated to grow a CAGR of 7.8% from 2022 to 2031.

What is the market share of the leading segment of the global joint pain injections market?

The hyaluronic acid injections segment held major share of the global joint pain injections market in 2021.

Which region will account for major share of the global market during the forecast period?

North America is expected to account for major share of the global joint pain injections market during the forecast period.

Who are the prominent players in the global joint pain injections market?

Pfizer, Inc., Anika Therapeutics, Inc., Bioventus, Eli Lilly and Company, Ferring B.V., Pacira BioSciences, Inc. (Flexion Therapeutics), Sanofi, Seikagaku Corporation, and Zimmer Biomet.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Joint Pain Injections Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Joint Pain Injections Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Regulatory Scenario by Region/globally

    5.3. Pipeline Analysis

    5.4. Disease Prevalence & Incidence Rate globally with key countries

    5.5. Covid-19 Impact Analysis

6. Global Joint Pain Injections Market Analysis and Forecast, by Joint Type

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Joint Type, 2017–2031

        6.3.1. Knee & Ankle

        6.3.2. Hip Joint

        6.3.3. Shoulder & Elbow

        6.3.4. Facet Joints of Spine

        6.3.5. Others

    6.4. Market Attractiveness Analysis, by Joint Type

7. Global Joint Pain Injections Market Analysis and Forecast, by Injection Type

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Injection Type, 2017–2031

        7.3.1. Corticosteroid Injections

        7.3.2. Hyaluronic Acid Injections

        7.3.3. Others

    7.4. Market Attractiveness Analysis, by Injection Type

8. Global Joint Pain Injections Market Analysis and Forecast, by Distribution Channel

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by Distribution Channel, 2017–2031

        8.3.1. Hospital Pharmacies

        8.3.2. Online Pharmacies

        8.3.3. Retail Pharmacies

    8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Joint Pain Injections Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Joint Pain Injections Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Joint Type, 2017–2031

        10.2.1. Knee & Ankle

        10.2.2. Hip Joint

        10.2.3. Shoulder & Elbow

        10.2.4. Facet Joints of Spine

        10.2.5. Others

    10.3. Market Value Forecast, by Injection Type, 2017–2031

        10.3.1. Corticosteroid Injections

        10.3.2. Hyaluronic Acid Injections

        10.3.3. Others

    10.4. Market Value Forecast, by Distribution Channel, 2017–2031

        10.4.1. Hospital Pharmacies

        10.4.2. Online Pharmacies

        10.4.3. Retail Pharmacies

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Joint Type

        10.6.2. By Injection Type

        10.6.3. By Distribution Channel

        10.6.4. By Country

11. Europe Joint Pain Injections Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Joint Type, 2017–2031

        11.2.1. Knee & Ankle

        11.2.2. Hip Joint

        11.2.3. Shoulder & Elbow

        11.2.4. Facet Joints of Spine

        11.2.5. Others

    11.3. Market Value Forecast, by Injection Type, 2017–2031

        11.3.1. Corticosteroid Injections

        11.3.2. Hyaluronic Acid Injections

        11.3.3. Others

    11.4. Market Value Forecast, by Distribution Channel, 2017–2031

        11.4.1. Hospital Pharmacies

        11.4.2. Online Pharmacies

        11.4.3. Retail Pharmacies

    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Italy

        11.5.5. Spain

        11.5.6. Rest of Europe

    11.6. Market Attractiveness Analysis

        11.6.1. By Joint Type

        11.6.2. By Injection Type

        11.6.3. By Distribution Channel

        11.6.4. By Country/Sub-region

12. Asia Pacific Joint Pain Injections Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Joint Type, 2017–2031

        12.2.1. Knee & Ankle

        12.2.2. Hip Joint

        12.2.3. Shoulder & Elbow

        12.2.4. Facet Joints of Spine

        12.2.5. Others

    12.3. Market Value Forecast, by Injection Type, 2017–2031

        12.3.1. Corticosteroid Injections

        12.3.2. Hyaluronic Acid Injections

        12.3.3. Others

    12.4. Market Value Forecast, by Distribution Channel, 2017–2031

        12.4.1. Hospital Pharmacies

        12.4.2. Online Pharmacies

        12.4.3. Retail Pharmacies

    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Market Attractiveness Analysis

        12.6.1. By Joint Type

        12.6.2. By Injection Type

        12.6.3. By Distribution Channel

        12.6.4. By Country/Sub-region

13. Latin America Joint Pain Injections Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Joint Type, 2017–2031

        13.2.1. Knee & Ankle

        13.2.2. Hip Joint

        13.2.3. Shoulder & Elbow

        13.2.4. Facet Joints of Spine

        13.2.5. Others

    13.3. Market Value Forecast, by Injection Type, 2017–2031

        13.3.1. Corticosteroid Injections

        13.3.2. Hyaluronic Acid Injections

        13.3.3. Others

    13.4. Market Value Forecast, by Distribution Channel, 2017–2031

        13.4.1. Hospital Pharmacies

        13.4.2. Online Pharmacies

        13.4.3. Retail Pharmacies

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Market Attractiveness Analysis

        13.6.1. By Joint Type

        13.6.2. By Injection Type

        13.6.3. By Distribution Channel

        13.6.4. By Country/Sub-region

14. Middle East & Africa Joint Pain Injections Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Joint Type, 2017–2031

        14.2.1. Knee & Ankle

        14.2.2. Hip Joint

        14.2.3. Shoulder & Elbow

        14.2.4. Facet Joints of Spine

        14.2.5. Others

    14.3. Market Value Forecast, by Injection Type, 2017–2031

        14.3.1. Corticosteroid Injections

        14.3.2. Hyaluronic Acid Injections

        14.3.3. Others

    14.4. Market Value Forecast, by Distribution Channel, 2017–2031

        14.4.1. Hospital Pharmacies

        14.4.2. Online Pharmacies

        14.4.3. Retail Pharmacies

    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Market Attractiveness Analysis

        14.6.1. By Joint Type

        14.6.2. By Injection Type

        14.6.3. By Distribution Channel

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis, by Company, 2021

    15.3. Company Profiles

        15.3.1. Pfizer, Inc.

            15.3.1.1. Company Overview

            15.3.1.2. Financial Overview

            15.3.1.3. Product Portfolio

            15.3.1.4. Business Strategies

            15.3.1.5. Recent Developments

        15.3.2. Anika Therapeutics, Inc.

            15.3.2.1. Company Overview

            15.3.2.2. Financial Overview

            15.3.2.3. Product Portfolio

            15.3.2.4. Business Strategies

            15.3.2.5. Recent Developments

        15.3.3. Bioventus

            15.3.3.1. Company Overview

            15.3.3.2. Financial Overview

            15.3.3.3. Product Portfolio

            15.3.3.4. Business Strategies

            15.3.3.5. Recent Developments

        15.3.4. Eli Lilly and Company

            15.3.4.1. Company Overview

            15.3.4.2. Financial Overview

            15.3.4.3. Product Portfolio

            15.3.4.4. Business Strategies

            15.3.4.5. Recent Developments

        15.3.5. Ferring B.V.

            15.3.5.1. Company Overview

            15.3.5.2. Financial Overview

            15.3.5.3. Product Portfolio

            15.3.5.4. Business Strategies

            15.3.5.5. Recent Developments

        15.3.6. Pacira BioSciences, Inc. (Flexion Therapeutics)

            15.3.6.1. Company Overview

            15.3.6.2. Financial Overview

            15.3.6.3. Product Portfolio

            15.3.6.4. Business Strategies

            15.3.6.5. Recent Developments

        15.3.7. Sanofi

            15.3.7.1. Company Overview

            15.3.7.2. Financial Overview

            15.3.7.3. Product Portfolio

            15.3.7.4. Business Strategies

            15.3.7.5. Recent Developments

        15.3.8. Seikagaku Corporation

            15.3.8.1. Company Overview

            15.3.8.2. Financial Overview

            15.3.8.3. Product Portfolio

            15.3.8.4. Business Strategies

            15.3.8.5. Recent Developments

        15.3.9. Zimmer Biomet

            15.3.9.1. Company Overview

            15.3.9.2. Financial Overview

            15.3.9.3. Product Portfolio

            15.3.9.4. Business Strategies

            15.3.9.5. Recent Developments

List of Tables

Table 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 02: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031

Table 03: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 04: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Region , 2017–2031

Table 05: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country, 2017–2031

Table 06: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 07: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031

Table 08: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 09: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 10: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 11: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 12: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 13: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 14: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031

Table 15: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 16: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 17: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 18: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031

Table 19: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

Table 20: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 21: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017–2031

Table 22: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017–2031

Table 23: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2031

List of Figures

Figure 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2021

Figure 03: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2021

Figure 04: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2021

Figure 05: Global Joint Pain Injection Market Value Share (%), by Region, 2021

Figure 06: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2017 and 2031

Figure 07: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2017 and 2031

Figure 08: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Injection Type, 2017–2031

Figure 09: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Knee & Ankle 2017–2031

Figure 10: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hip Joint, 2017–2031

Figure 11: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Shoulder & Elbow, 2017–2031

Figure 12: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Facet Joints of Spine, 2017–2031

Figure 13: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 14: Global Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2021–2031

Figure 15: Global Joint Pain Injection Market Attractiveness Analysis, by Injection Type, 2021–2031

Figure 16: Global Joint Pain Injection Market Attractiveness Analysis, by Devices, 2021–2031

Figure 17: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031

Figure 18: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2021–2031

Figure 19: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroid Injections, 2017–2031

Figure 20: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hyaluronic Acid Injections, 2017–2031

Figure 21: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2031

Figure 22: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031

Figure 23: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel

Figure 24: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017–2031

Figure 25: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017–2031

Figure 26: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017–2031

Figure 27: Global Joint Pain Injection Market Value Share Analysis, by Region, 2017 and 20231

Figure 28: Global Joint Pain Injection Market Attractiveness Analysis, by Region, 2021-2031

Figure 29: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 30: North America Joint Pain Injection Market Value Share (%), by Country, 2017 and 2031

Figure 31: North America Joint Pain Injection Market Attractiveness Analysis, by Country, 2022–2031

Figure 32: North America Joint Pain Injection Market Value Share, by Joint Type, 2017and 2031

Figure 33: North America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031

Figure 34: North America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031

Figure 35: North America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 36: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 37: Europe Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017and 2031

Figure 38: Europe Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 39: Europe Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031

Figure 40: Europe Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031

Figure 41: Europe Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031

Figure 42: Europe Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 43: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 44: Asia Pacific Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 45: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 46: Asia Pacific Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031

Figure 47: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031

Figure 48: Asia Pacific Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031

Figure 49: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Figure 50: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 51: Latin America Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 52: Latin America Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 53: Latin America Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031

Figure 54: Latin America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2017–2031

Figure 55: Latin America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031

Figure 56: Latin America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2017–2031

Figure 57: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 58: Middle East & Africa Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031

Figure 59: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 60: Middle East & Africa Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031

Figure 61: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022–2031

Figure 62: Middle East & Africa Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031

Figure 63: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022–2031

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

968

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved